Exact Mass: 444.272304
Exact Mass Matches: 444.272304
Found 200 metabolites which its exact mass value is equals to given mass value 444.272304
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
sn-3-O-(geranylgeranyl)glycerol 1-phosphate
C23H41O6P (444.26406160000005)
MG(6 keto-PGF1alpha/0:0/0:0)
MG(6 keto-PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(TXB2/0:0/0:0)
MG(TXB2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/6 keto-PGF1alpha/0:0)
MG(0:0/6 keto-PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/TXB2/0:0)
MG(0:0/TXB2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
12-amino-6,9-di-sec-butyl-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione
geranyl-1-O-alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside
Dicadalenol|rel-1beta,7-Dihydroxy-2betaH-1,2,3,4-tetrahydro-14,8,2(O),7-dicadalenol
Ala Asn Ile Lys
Ala Ala Lys Arg
Ala Ala Arg Lys
Ala Ile Lys Asn
Ala Ile Asn Lys
Ala Lys Ala Arg
Ala Lys Ile Asn
Ala Lys Leu Asn
Ala Lys Asn Ile
Ala Lys Asn Leu
Ala Lys Gln Val
Ala Lys Arg Ala
Ala Lys Val Gln
Ala Leu Lys Asn
Ala Leu Asn Lys
Ala Asn Lys Ile
Ala Asn Lys Leu
Ala Asn Leu Lys
Ala Gln Lys Val
Ala Gln Val Lys
Ala Arg Ala Lys
Ala Arg Lys Ala
Ala Val Lys Gln
Ala Val Gln Lys
Gly Ile Lys Gln
Gly Ile Gln Lys
Gly Lys Ile Gln
Gly Lys Leu Gln
Gly Lys Gln Ile
Gly Lys Gln Leu
Gly Leu Lys Gln
Gly Leu Gln Lys
Gly Gln Ile Lys
Gly Gln Lys Ile
Gly Gln Lys Leu
Gly Gln Leu Lys
Ile Ala Lys Asn
Ile Ala Asn Lys
Ile Gly Lys Gln
Ile Gly Gln Lys
Ile Lys Ala Asn
Ile Lys Gly Gln
Ile Lys Asn Ala
Ile Lys Gln Gly
Ile Asn Ala Lys
Ile Asn Lys Ala
Ile Gln Gly Lys
Ile Gln Lys Gly
Lys Ala Ala Arg
Lys Ala Ile Asn
Lys Ala Leu Asn
Lys Ala Asn Ile
Lys Ala Asn Leu
Lys Ala Gln Val
Lys Ala Arg Ala
Lys Ala Val Gln
Lys Gly Ile Gln
Lys Gly Leu Gln
Lys Gly Gln Ile
Lys Gly Gln Leu
Lys Ile Ala Asn
Lys Ile Gly Gln
Lys Ile Asn Ala
Lys Ile Gln Gly
Lys Leu Ala Asn
Lys Leu Gly Gln
Lys Leu Asn Ala
Lys Leu Gln Gly
Lys Asn Ala Ile
Lys Asn Ala Leu
Lys Asn Ile Ala
Lys Asn Leu Ala
Lys Gln Ala Val
Lys Gln Gly Ile
Lys Gln Gly Leu
Lys Gln Ile Gly
Lys Gln Leu Gly
Lys Gln Val Ala
Lys Arg Ala Ala
Lys Val Ala Gln
Lys Val Gln Ala
Leu Ala Lys Asn
Leu Ala Asn Lys
Leu Gly Lys Gln
Leu Gly Gln Lys
Leu Lys Ala Asn
Leu Lys Gly Gln
Leu Lys Asn Ala
Leu Lys Gln Gly
Leu Asn Ala Lys
Leu Asn Lys Ala
Leu Gln Gly Lys
Leu Gln Lys Gly
Asn Ala Ile Lys
Asn Ala Lys Ile
Asn Ala Lys Leu
Asn Ala Leu Lys
Asn Ile Ala Lys
Asn Ile Lys Ala
Asn Lys Ala Ile
Asn Lys Ala Leu
Asn Lys Ile Ala
Asn Lys Leu Ala
Asn Leu Ala Lys
Asn Leu Lys Ala
Gln Ala Lys Val
Gln Ala Val Lys
Gln Gly Ile Lys
Gln Gly Lys Ile
Gln Gly Lys Leu
Gln Gly Leu Lys
Gln Ile Gly Lys
Gln Ile Lys Gly
Gln Lys Ala Val
Gln Lys Gly Ile
Gln Lys Gly Leu
Gln Lys Ile Gly
Gln Lys Leu Gly
Gln Lys Val Ala
Gln Leu Gly Lys
Gln Leu Lys Gly
Gln Val Ala Lys
Gln Val Lys Ala
Arg Ala Ala Lys
Arg Ala Lys Ala
Arg Lys Ala Ala
Val Ala Lys Gln
Val Ala Gln Lys
Val Lys Ala Gln
Val Lys Gln Ala
Val Gln Ala Lys
Val Gln Lys Ala
AL 8810 isopropyl ester
LPA O-20:4
C23H41O6P (444.26406160000005)
[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]diethylammonium acetate
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyl-24-oxotetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenoic acid
1-[(2,4-dimethoxyphenyl)methyl]-N-(2-phenylethyl)-N-(phenylmethyl)-4-piperidinamine
3-O-(geranylgeranyl)glycerol 1-phosphate
C23H41O6P (444.26406160000005)
1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
sn-1-O-(geranylgeranyl)glycerol 3-phosphate
C23H41O6P (444.26406160000005)
(3r,4s,5s,6r,7r,8r)-5,6,7-trihydroxy-2,2,4,6,8-pentamethyl-9-oxooxonan-3-yl (2e,4r)-4-hydroxydec-2-enoate
(3r,8as)-5-propyl-3-(tetradecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(3r,8ar)-3-(hexadecyloxy)-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
3-(hexadecyloxy)-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(8ar)-5-methyl-3-[(14-methylpentadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(4e)-13-{5-[(9e)-11-hydroxytridec-9-en-1,12-diyn-1-yl]furan-2-yl}tridec-4-en-1,12-diyn-3-ol
(2e,4e,6e,8e,10e,12z,14z,16e)-17-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohexa-1,4-dien-1-yl)-2,6,11,15-tetramethylheptadeca-2,4,6,8,10,12,14,16-octaenal
(3r,8as)-5-butyl-3-(tridecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
5-methyl-3-[(14-methylpentadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(3r,8as)-5-(2-methylpropyl)-3-(tridecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(3r,8ar)-5-methyl-3-[(14-methylpentadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
3,4a,5-trimethyl-2-{3,5,9-trimethyl-6h,7h,8h,9h-naphtho[1,2-b]furan-2-yl}-4h,5h,6h,7h,9h-naphtho[2,3-b]furan-4-ol
(3r,8as)-5-ethyl-3-(pentadecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
2-[(3,7-dimethylocta-2,6-dien-1-yl)oxy]-6-({[5-(hydroxymethyl)-3,4-dimethyloxolan-2-yl]oxy}methyl)oxane-3,4,5-triol
5,6,7-trihydroxy-2,2,4,6,8-pentamethyl-9-oxooxonan-3-yl 4-hydroxydec-2-enoate
8,16-diisopropyl-5,11,19-trimethyl-13-oxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3(12),4,6,8,10,17(22),18,20-octaene-1,20-diol
(2r,3r,4s,5s,6r)-2-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-6-({[(2r,3r,4r,5s)-5-(hydroxymethyl)-3,4-dimethyloxolan-2-yl]oxy}methyl)oxane-3,4,5-triol
(1r,14r,16s)-8,16-diisopropyl-5,11,19-trimethyl-13-oxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3(12),4,6,8,10,17(22),18,20-octaene-1,20-diol
(2r,3r,4s,5s,6r)-2-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-6-({[(2r,3r,4r,5r)-5-(hydroxymethyl)-3,4-dimethyloxolan-2-yl]oxy}methyl)oxane-3,4,5-triol
(8ar)-3-(hexadecyloxy)-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)